Table I.
Clinical parameters | N | Tβ4 PR (%) | χ2 | P-value |
---|---|---|---|---|
Gender | ||||
M | 14 | 9 (64) | 0.13 | >0.05 |
F | 5 | 3 (60) | ||
Age | ||||
<3 years | 13 | 8 (61) | 0.00 | >0.05 |
≥3 years | 6 | 4 (67) | ||
Tumor subtype | ||||
Fetal | 9 | 6 (67) | ||
Embryonal | 5 | 3 (60) | 0.23 | >0.05 |
Undifferentiated | 2 | 2 (67) | ||
Epithelial/mesenchymal | 3 | 1 (50) | ||
Lymph node metastasis | ||||
Yes | 11 | 10 (91) | 8.65 | <0.01 |
No | 8 | 2 (25) |
M, male; F, female; N, number; Tβ4 PR, thymosin β4 positive rate.